TITLE

Administration of Heparin by Continuous Intravenous Infusion in the Treatment of Deep Venous Thrombosis

AUTHOR(S)
Erdem, Erhan; Uncu, Hakan
PUB. DATE
April 1994
SOURCE
Vascular Surgery;Apr1994, Vol. 28 Issue 3, p177
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
In this prospective study the authors compared two approaches to heparin therapy, in the treatment of deep venous thrombosis-continuous infusion heparin and intermittent heparin therapy. Each group was comparable with respect to age, gender, risk factors, and etiologic factors. The continuous infusion group (n=60) received a heparin bolus of 150 U/kg followed by continuous intravenous infusion of 750 U/kg/twenty-four hours. The intermittent group (n=60) received a bolus of 5000 U in every four hour period. In the infusion therapy group, the resolution of clinical symptoms was more rapid, so the hospitalization time was shorter, and the hemorrhagic complications and relapses were fewer than with intermittent therapy. The authors conclude that administration of heparin by continuous infusion appears to be effective and safer than intermittent injection therapy.
ACCESSION #
16758000

 

Related Articles

  • Managing heparin infusions. Brown, Nicholas F.; Bart-Smith, Emily; Gillett, Donald // British Journal of Hospital Medicine (17508460);Jun2012 Supplement, pC85 

    The article offers guidance on the use of unfractionated heparin infusions. It describes the pharmacology of heparin and its indication in the prevention and treatment of various conditions particularly among patients with renal failure or a high risk of bleeding. Information on heparin dosing...

  • Control and Management of Heparin Therapy in Venous Thromboembolism. Almazán, A.; Lozano, F.; Ramos, M.; Gómez-Alonso, A. // Vascular Surgery;Jan/Feb1983, Vol. 17 Issue 1, p1 

    The precise management of Deep Venous Thrombosis (DVT), and its complications, is of considerable clinical importance as well as being a controversial topic. However, the standard treatment or complementary of others, as well as the one accepted as being of less risk and more effectiveness is...

  • Heparin.  // Reactions Weekly;Aug2015, Vol. 1563 Issue 1, p114 

    The article presents a case study of a 51-year-old male who developed a retroperitoneal haemorrhage while being treated with IV heparin for deep vein thrombosis.

  • Hirudin therapy during thrombolysis for venous thrombosis in heparin-induced thrombocytopenia. Reilly, M.P.; Weiss, R.; Askenase, A.; Tuite, C.; Soulen, M.; Mohler III, E.R. // Vascular Medicine;2000, Vol. 5 Issue 4, p239 

    Heparin-induced thrombocytopenia (HIT) is the most common drug-related thrombocytopenia. Thromboembolic complications occur in approximately 50% of patients with HIT and result in limb amputation and death in up to 20% and 30% respectively. Because patients with a history of HIT may require...

  • Monitoring of High-Dose Intravenous Heparin Therapy--A Contribution to the Safety of Heparin Monitoring. Haushofer, Alexander; Halbmayer, Walter Michael; Radek, Johannes; Fischer, Michael // Clinical & Applied Thrombosis/Hemostasis;Summer1996, Vol. 2 Issue 3, p177 

    Whenever unfractionated heparin (UFH) is administered i.v. in therapeutic doses, therapeutic drug monitoring of the anticoagulant response should be mandatory and the dose should be adjusted accordingly. UFH therapy is usually monitored by the activated partial thromboplastin time (APTT). A 1.5-...

  • Pharmacokinetics ofN-acetylcysteine following repeated intravenous infusion in haemodialysed patients. Soldini, Davide; Zwahlen, Hugo; Gabutti, Luca; Marzo, Antonio; Marone, Claudio // European Journal of Clinical Pharmacology;Feb2005, Vol. 60 Issue 12, p859 

    Objective: N-acetylcysteine (NAC) is a mucolytic agent with anti-oxidant properties. It might have potential positive effects in renal patients and, therefore, its pharmacokinetics and safety in haemodialysis was investigated. Methods: Twelve dialysis patients received 2 g NAC (10 ml NAC 20%...

  • Candidal Suppurative Peripheral Thrombophlebitis. Torres-Rojas, Jaime R.; Stratton, Charles W.; Sanders, Charles V.; Horsman, Thomas A.; Hawley, H. Bradford; Dascomb, Harry E.; Vial, Jr., L.J. // Annals of Internal Medicine;Apr82, Vol. 96 Issue 4, p431 

    Presents case reports in which patients had sustained candidemia associated with suppurative peripheral thrombophlebitis that occurred during intravenous therapy. Patients and methods; Discussion.

  • Role of acidic pH of intravenous fluids in subsequent development of metabolic acidosismay not be what it seems. Saikia, Priyam; Choudhury, Dipika; Bora, Bikash B. // Indian Journal of Critical Care Medicine;Jul2014, Vol. 18 Issue 7, p484 

    A letter to the editor is presented in response to an article on the controversies surrounding the use of acidic intravenous fluids (IVFs) infusion.

  • N.Y. study evaluating computerized heparin alerts. DeBenedette, Valerie // Drug Topics;3/17/2003, Vol. 147 Issue 6, p44 

    Reports on the department of pharmacy at New York Presbyterian Hospital in Manhattan's study to evaluate a computerized order entry system for intravenous unfractionated heparin. Comparison of the computerized system to a printed order form; Goal of the study; Advantages of low-molecular-weight...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics